Evidence map›Paper›PMID 23062569›Full record

ReviewThe American journal of cardiology2012

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Cecilia C Low Wang, Jane E B Reusch

Open access · greenAbstract readReview
In one paragraph

Review in The American journal of cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Practical Approach to Hypertension Management in Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2017
    Review
  12. Review
  13. Perceptions of Adolescent Patients of the "Lived Experience" of Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2017
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cecilia C Low WangUniversity of Colorado Anschutz Medical Campus, Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, Aurora, Colorado, and Denver Veterans Affairs Medical Center, Denver, Colorado 80045, USA. cecilia.wang@ucdenver.edu
Jane E B Reusch
University of Colorado Anschutz Medical Campus · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Transcriptional Regulation of PDGF Receptor AlphaR01DK064741 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REUSCH, JANE E · 2004 to 2009
$1.6M
NCRR NIH HHS UL1 RR025780NIDDK NIH HHS R01 DK064741
6 · The paper itself

Abstract

Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including CAD, stroke, peripheral vascular disease, and other vascular disease. While glycemic management remains a cornerstone of DM care, the co-management of hypertension, atherosclerosis, cardiovascular risk reduction, and prevention of long-term consequences associated with DM are now well recognized as essential to improve long-term survival. Clinical trial evidence substantiates the importance of glycemic control, low-density cholesterol-lowering therapy, blood pressure lowering, control of albuminuria, and comprehensive approaches targeting multiple risk factors to reduce cardiovascular risk. This article presents a review of the role of DM in the pathogenesis of atherosclerosis and cardiac dysfunction, recent evidence on the degree of glycemic control and mortality, and available evidence for a multifaceted approach to improve long-term outcomes for patients.

Indexed as

AlbuminuriaAnticholesteremic AgentsAntihypertensive AgentsCardiovascular DiseasesDiabetes ComplicationsExercise TherapyHumansHyperglycemiaRisk FactorsAnticholesteremic AgentsAntihypertensive Agents

Identifiers

PMID23062569
PMCPMC3480668
OpenAlexW1981254311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.